SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-10-065825
Filing Date
2010-12-10
Accepted
2010-12-10 16:13:56
Documents
4
Period of Report
2009-10-31

Document Format Files

Seq Description Document Type Size
1 v204775_10qa.htm 10-Q/A 1089891
2 v204775_ex31-1.htm EX-31.1 15434
3 v204775_ex31-2.htm EX-31.2 15416
4 v204775_ex32.htm EX-32 8489
  Complete submission text file 0001144204-10-065825.txt   1130678
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q/A | Act: 34 | File No.: 000-25169 | Film No.: 101245157
SIC: 2834 Pharmaceutical Preparations